Both can rise as primary, de novo, lesions or from the transformation of pre-existing benign lesions, through mutations in different genes: central chondrosarcoma from enchondroma (IDH mutations), peripheral from osteochondroma (EXT1, EXT2 mutations) [3]. The gene discussed is IDH2; the disease is chondrosarcoma.